Holy genomic sequences, Batman

...they're making another bioweapon

Under Fauci’s guidance of the NIAID (National Institute of Allergy and Infectious Diseases) division of the National Institute of Health, a PPD (Pandemic Preparedness Plan) was established in December of 2021. Here is a link to the document: https://www.niaid.nih.gov/sites/default/files/pandemic-preparedness-plan.pdf

The last sentence of the document states, “Through multiple mechanisms, NIAID also will coordinate its programs with foreign government entities; international organizations, including WHO, the Global Fund, CEPI, GAVI, BMGF, and others; and domestic and international academic, private sector, and NGO entities.” If you haven’t figured it out by now, this is all about global control of EVERYTHING and EVERYONE by creating fear and panic and offering global solutions to manufactured global “pandemics” and if you don’t go along with the plan, you will no longer be able to function in society.

Fear and panic can be created around a pathogen pandemic that they will convince you will kill you if you come in contact with it. The global solution is mRNA technology injections to induce the cells of the injected to make parts of the pathogen to “protect” them. Fear and panic can be created around a pandemic of financial institution collapses. The global solution is CBDC (Central Bank Digital Currency) that can track and control your transactions. Fear and panic can be created around a pandemic of global warming or similar environmental issues. The global solution is restriction to energy production and consumption, food production and consumption, and even how far you are allowed to travel. Biden has signed off on the ability of the WHO to declare these types of pandemics and agrees to follow WHO mandates, directives and solutions. Thankfully, a bill has been introduced to defund the WHO: https://www.washingtonexaminer.com/news/chip-roy-bill-defund-who-ccp-praise-abortion President Trump defunded the WHO, Biden promptly refunded it.

The PPD states: “In addition to known threats, effective preparedness must also account for unexpected emerging disease threats, commonly referred to as Pathogen(s) X. To mitigate risks associated with these yet unknown pathogens, NIAID will prioritize preparedness research on prototype pathogens, which are select pathogens identified from viral families known to infect humans.” What are prototype pathogens? They are manmade genetically modified viruses that attempt to predict what mutations might occur. This was written about in 2020 in the paper titled “Prototype pathogen approach for pandemic preparedness: world on fire”: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7324162/ If these manmade viruses escape or are released, they are bioweapons. Then, they will design a vaccine “countermeasure” that will use the mRNA platform to induce the cells in human recipients to create the bioweapon protein so that antibodies against the predicted future pathogen will result. When that happens, the injection also becomes the bioweapon because the protein production results in pathologies.

Moderna is testing a new bioweapon on humans right now. It’s called MRNA-1215. It is targeting another bat virus, the Nipah virus (NiV). You can read about the trial on clinicaltrials.gov right here: https://clinicaltrials.gov/ct2/show/NCT05398796?cond=Nipah+Virus+Infection&draw=2&rank=2

Here’s the synopsis. The sponsor is NIAID. The collaborator is Moderna TX, Inc. The mRNA-1215 was co-developed by the Vaccine Research Center (VRC), National Institute of Allergy and Infectious Disease (NIAID) and ModernaTX, Inc, and manufactured by ModernaTX. The mRNA codes for the production of the G protein on the Nipah virus that binds to receptors on human cells. Sound familiar? It should, because Moderna’s MRNA-1273 in the covid shot coded for the S protein on the Sars-CoV-2 virus that binds to receptors on human cells. They are using the same playbook. They found out the hard way that the protein coded by MRNA-1273 in the covid shot is toxic and causes significant changes to the physiology of vasculature and other tissues, resulting in symptoms and sometimes untimely deaths. The toxic protein created by the shot results in antibody production for sure, and that is the goal of the injection. Unfortunately, it’s the wrong antibody. The antibody reacts to the protein created by the shot, not what is on the virus…that protein has mutated. Therefore, the shot provides no protection. In fact, through mechanisms called Antibody Dependent Enhancement of Infection and Antibody Dependent Enhancement of Disease, the antibody created against the protein coded in the shot will make infection easier and symptoms worse. The protein created from MRNA-1215 could end up doing the same things.

Before we dig into the proteins coded by the shots, we need to discuss viruses for a minute. Viruses are not living things. They have no intelligence, no desire to attack you, no desire to copy themselves, and no ability to mutate themselves. Viruses are genetic material inside of a shell made of proteins and sometimes proteins and fats. In order for that genetic material to affect you in any way, it must get inside of you. The generally accepted way it gets inside of you is by your living cells allowing the virus to attach to specialized receptors on cell surfaces. Viruses have proteins, usually called spike proteins because they stick out, on their outer shell surface that can attach to those special cell receptors. After the attachment, there is either a merge of the cell membrane with the virus membrane so that the genetic information inside of the virus can be pulled in and used by the cell. Or the entire virus is pulled into the cell in an endosome which breaks down to release the virus and its genetic material. Once the genetic material is inside the cell, it is used to make new proteins to change cellular function, or it is used to make more copies of the virus so that they can be released from the cell to affect more cells. Those are the generally accepted ways the genetic material enters cells, but we will never be able to watch that happen due to the limitations of electron microscopy. Other methods of genetic material transfer have been postulated including different frequencies of electromagnetic radiation.

Some will say there is no virus. To them I say, you can find genetic material that is not human DNA in people who are sick, and the same genetic material in people who are not sick. You can take that genetic material and expose it to dead cells, and nothing happens. But, when you expose it to living cells, you end up with more of it. This is measurable and repeatable. Living cells will make more copies of the genetic material under certain conditions. If those living cells are part of a human body, symptoms might appear or might not appear. So, the genetic material transfers between humans, but symptoms do not. Whether symptoms will appear, and how severe they are depends mostly on the condition of the immune system.

The transmissibility of the genetic material is dependent upon where the cellular receptors are. Many of the receptors for the Sars-CoV-2 genetic material are on the mucosal barrier of the airway, called the epithelium. Therefore, the genetic material, not the symptoms, can transmit through the air. For other viruses, like Ebola or Marburg, there are no receptors on the epithelium. The genetic material of those viruses require direct contact with your blood through breaks in mucosal linings, therefore outbreaks of the symptoms of those diseases are rare. However, outbreaks of symptoms will become more common if people are convinced to willingly inject parts of the genetic material of those viruses into themselves.

The receptors for the Nipah virus are ephrin-b2 and ephrin-b3. Those receptors are on cell surfaces that are mostly inside of you, along the lining of your blood vessels, called the endothelium. They also exist on smooth muscle cells that are in blood vessel walls. They are also found on nerve tissue cells including neurons and glial cells in the brain. There are a few on the epithelial lining of the airway including the alveoli of the lungs, but not nearly as many as the ACE2 receptors used by the S protein on the Sars-CoV-2 virus. The risk of airborne transmission of NiV is low, but the WHO still considers it to be a significant threat, therefore the push for a shot called a vaccine to make antibodies against the G protein on it.

The trial is taking place at the NIH clinical center in Bethesda, Maryland. The first dose was administered on July 12, 2022 and is expected to be completed by June of 2024. The trial for NIAID’s MRNA-1215 is looking for 50 healthy, unpregnant people aged 18 to 60 who are willing to inject themselves with the message to make the G glycoprotein part of the Nipah virus that attaches to the endothelial lining of blood vessels. They want to see how well this is tolerated, and whether or not it will result in antibody production. It most certainly will result in antibody production. Any nonself protein injected into the blood, lymph or tissues will result in antibody production. That is what the adaptive immune system is supposed to do. They will split the 40 to 50 volunteers into 4 groups and inject them with different amounts of the MRNA-1215 to see how many antibodies are produced with increasing amounts, and how well these groups tolerate the injections. There is no placebo group because they are not looking to see if the shot prevents symptoms, they just want to see what it does and if anyone gets hurt by it.

Most concerning is the fact that the MRNA-1215 that codes for the G protein is encapsulated in a lipid nanoparticle that is made of normal body fats, just like the MRNA-1273 was in the covid shot. These lipid nanoparticles will be able to cross the blood brain barrier and merge with the membranes of ANY cells they come in contact with. The Nipah virus itself though, will only be able to attach to and be replicated by human cells that have the ephrin-b2, b3 receptors. This means that in a natural NiV infection, only those specific cells with the virus attached to those receptors will be targeted by the immune system. There will be far fewer of them being attacked than the numbers and types of cells that will get attacked after being injected with MRNA-1215. This is why the shot is a bioweapon. After being injected, when those cells start making the G glycoprotein and secrete it, the immune system of the body will attack those cells. If it is widespread throughout the body, Multi-Inflammatory Syndrome (MIS) will be the result. Once the G proteins start circulating, they will naturally attach to the ephrin-b2, b3 receptors. This could result in blood clots and inflammation all along the vasculature, in the heart (myocarditis), and in brain tissue (encephalitis).  

Worse, the antibody that will be created against the G protein manufactured by cells could result in autoimmune reactions to normal body proteins that are similar to parts of the G protein. The amino acid sequence for the G protein on the Nipah virus is published here: https://www.ncbi.nlm.nih.gov/nuccore/AF212302.2 Copy the sequence and paste it into the SVMTriP tool here: http://sysbio.unl.edu/SVMTriP/prediction.php You will see a region of the amino acid sequence on the G protein that is predicted to be an unsafe epitope as it closely matches a normal amino acid sequence that is a gene that codes for a TNF (Tumor Necrosis Factor) receptor in the human body. I’m not saying autoimmunity will happen, but it can happen, and is almost always listed as an AESI (Adverse Event of Special Interest) in vaccine trials.

Also of concern is ongoing bat virus research. Bats harbor many viruses that have the potential to affect humans. The research takes the Nipah virus from the bats and exposes it to live cell cultures in laboratories, allowing the cells to replicate the virus. They will do this many times over, allowing the cells to mutate the virus faster than mutations will occur in nature. This is called serial passage or directed evolution. The potential always exists for a mutated form of the virus to escape the laboratory. A new bat research facility has been approved for construction at the Colorado State University Foothills Campus in Fort Collins by an NIH grant: https://source.colostate.edu/csu-awarded-6-7-million-nih-award-for-research-facility-focused-on-bat-health-disease-transmission/ This facility will import bats that are not indigenous to the United States and perform dangerous virus research. They will rationalize the necessity of this research by trying to stay a step ahead of nature and having a “vaccine” ready to go. The truth is, they are artificially inducing the conditions necessary for the emergence of a potential pathogen that might not occur naturally. This must stop.